Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
UK STAR logo

The UKSTAR (UK Study of tendo Achilles Rehabilitation) trial has opened its first pilot site for recruitment. King’s College Hospital in London is now recruiting patients for the trial which is comparing plaster casts to walking boots for patients who have suffered an Achilles tendon rupture and are being treated non-operatively. The trial will gradually be rolled out with the aim of eventually opening the trial in at least 22 hospitals across the UK.

Participants who are aged 16 or over, have suffered a primary Achilles tendon rupture and are being treated non-operatively will be eligible to take part. The primary outcome for the trial is to quantify and draw inferences on observed differences in Achilles Tendon Rupture Score (a patient reported outcome) between the trial treatment groups at 9 months after injury. The trial will also collect important information for secondary outcomes on quality of life, complications, resource use, costs and comparative cost effectiveness

Similar stories

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.

International Clinical Trials Day

Researchers across the world celebrate International Clinical Trials Day today. We have produced a short animation this year to mark the occasion...

Clinical trial finds Azithromycin has no benefit against COVID-19

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.